Detalles de la búsqueda
1.
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry.
Lancet Oncol
; 24(4): 335-346, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36898391
2.
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study.
Lancet Oncol
; 23(7): 865-875, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35660139
3.
Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer.
Br J Cancer
; 127(10): 1787-1792, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35995934
4.
Long-term effects of COVID-19 on cancer patients: the experience from Guy's Cancer Centre.
Future Oncol
; 18(32): 3585-3594, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36172860
5.
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study.
Lancet Oncol
; 22(12): 1669-1680, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34741822
6.
Risk of COVID-19 death in cancer patients: an analysis from Guy's Cancer Centre and King's College Hospital in London.
Br J Cancer
; 125(7): 939-947, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34400804
7.
Palbociclib and endocrine therapy in heavily pretreated hormone receptor-positive HER2-negative advanced breast cancer: the UK Compassionate Access Programme experience.
Breast Cancer Res Treat
; 174(3): 731-740, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30656459
8.
Amplification-Free Detection of Circulating microRNA Biomarkers from Body Fluids Based on Fluorogenic Oligonucleotide-Templated Reaction between Engineered Peptide Nucleic Acid Probes: Application to Prostate Cancer Diagnosis.
Anal Chem
; 88(16): 8091-8, 2016 08 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-27498854
9.
Androgen-regulated processing of the oncomir miR-27a, which targets Prohibitin in prostate cancer.
Hum Mol Genet
; 21(14): 3112-27, 2012 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22505583
10.
Impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in patients with soft tissue sarcoma: an analysis from the OnCovid registry.
Ther Adv Med Oncol
; 16: 17588359231225028, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38249336
11.
Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registry.
Int J Infect Dis
; 139: 13-20, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38029831
12.
Pathologic Lymph Node Regression After Neoadjuvant Chemotherapy Predicts Recurrence and Survival in Esophageal Adenocarcinoma: A Multicenter Study in the United Kingdom.
J Clin Oncol
; 41(28): 4522-4534, 2023 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37499209
13.
Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer.
J Clin Oncol
; 41(15): 2800-2814, 2023 05 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36720089
14.
The Impact of COVID-19 on the Delivery of Systemic Anti-Cancer Treatment at Guy's Cancer Centre.
Cancers (Basel)
; 14(2)2022 Jan 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35053432
15.
Time-Dependent COVID-19 Mortality in Patients With Cancer: An Updated Analysis of the OnCovid Registry.
JAMA Oncol
; 8(1): 114-122, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34817562
16.
COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry.
J Natl Cancer Inst
; 114(7): 979-987, 2022 07 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35417006
17.
Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries.
J Immunother Cancer
; 10(11)2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36450384
18.
COVID-19 Risk Factors for Cancer Patients: A First Report with Comparator Data from COVID-19 Negative Cancer Patients.
Cancers (Basel)
; 13(10)2021 May 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34069565
19.
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study.
Eur J Cancer
; 150: 190-202, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33932726
20.
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score.
J Immunother Cancer
; 9(3)2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33753569